Form 8-K BOSTON SCIENTIFIC CORP For: Oct 23
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- Wall St slips as Gulf tensions send oil to over six-week high
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Citi initiates UiPath coverage with Buy rating and $23 target
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- Trump says Canada's Bombardier must build jets in US or lose market access
- Qualcomm to issue warrant to Amazon for up to 25M shares
- Wall St slips as Gulf tensions send oil to over six-week high
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Boston Scientific (BSX) PT Raised to $98 at RBC Capital
October 24, 2024 6:37 AM EDTRBC Capital analyst Shagun Singh raised the price target on Boston Scientific (NYSE: BSX) to $98.00 (from $95.00) while maintaining a Outperform rating.
The analyst comments "BSX reported impressive Q3'24 results (+18% y/y organic or 1,120bps above end-markets, and 26% y/y EPS growth)... More
CL King Reiterates Buy Rating on Boston Scientific (BSX)
October 24, 2024 6:34 AM EDTCL King analyst Kristen Stewart reiterated a Buy rating and $90.00 price target on Boston Scientific (NYSE: BSX)
The analyst comments "Boston Scientific (BSX) reported 3Q24 results that came in well above consensus expectations. We expect the stock to react favorably to the... More
